Short answer
Lument Finance Trust, Inc. (LFT) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 3.01 (Notice of Delisting), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Exhibit 99.1 contains the substantive delisting disclosure and is incorporated by reference.
- This filing includes Item 3.01, an item that often signal trouble.
Lument Finance Trust, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- Exhibit 99.1 contains the substantive delisting disclosure and is incorporated by reference
- Investors should review Exhibit 99.1 for the affected security, exchange, delisting timeline, and shareholder impact
Item 7.01 · Regulation FD Disclosure
- Potential NYSE continued-listing deficiency cure includes a reverse stock split
- Management evaluating alternatives to regain NYSE compliance
- Listing uncertainty creates potential trading and shareholder-impact risk
- Exhibit 99.1 furnished, not filed under Exchange Act Section 18 liability provisions
Item EX-99.1 · Exhibit EX-99.1
- NYSE deficiency notice triggered by common stock averaging below $1.00 for 30 consecutive trading days
- Trading continues normally during six-month cure period ending January 24, 2027
- Compliance requires $1.00 closing price and $1.00 30-day average on a month-end testing date
- Potential reverse stock split under consideration, subject to corporate approvals, with no selected action yet
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Lument Finance Trust, Inc. 8-K filings
Get the next LFT 8-K as it lands
Follow LFT for push alerts, or ask the research agent what this filing means.